Cyclacel Announces Private Placement Financing for Up to $22.1 Million
October 05, 2010 09:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel to Present at BIO Investor Forum
September 29, 2010 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Sept. 29, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals Reaches Agreement With FDA on a Special Protocol Assessment for Pivotal Phase 3 Trial of Sapacitabine in AML
September 13, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Sept. 13, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC), (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel to Present at Annual Rodman & Renshaw Healthcare Conference
September 08, 2010 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals' 6% Convertible Exchangeable Preferred Stockholders Request Special Meeting to Elect Directors
August 13, 2010 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 13, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals Reports Second Quarter 2010 Financial Results
August 05, 2010 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 5, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals to Announce Release of Second Quarter 2010 Financial Results
July 29, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., July 29, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), will announce second quarter 2010 financial results on Thursday, August 5, 2010....
Cyclacel Pharmaceuticals Announces FDA Orphan Drug Designation for Sapacitabine in Both AML and MDS
July 01, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., July 1, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Pharmaceuticals Added to Russell Microcap Index
June 28, 2010 09:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 28, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...
Cyclacel Answers Celgene's Declaratory Judgment Complaint and Counterclaims for Infringement of Four Cyclacel Patents
June 18, 2010 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., June 18, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various...